Modifier Locus on Mouse Chromosome 3 for Renal Vascular Pathology in AT1A Receptor-Deficiency

Hypertension

Volumn 43, Issue 2, 2004, Pages 445-451

  Le, Thu H ^a   Fogo, Agnes B ^a   Salzler, Harmony R ^a   Vinogradova, Tania ^a   Oliverio, Michael I ^a   Marchuk, Douglas A ^a   Coffman, Thomas M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiotensin II, genetics; Kidney; Receptors; Survival; Vessels

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN RECEPTOR; UNCLASSIFIED DRUG;

AGTR1A GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACKCROSSING; CHROMOSOME 3; CONFERENCE PAPER; CONTROLLED STUDY; DNA MODIFICATION; GENE; GENE DISRUPTION; GENE TARGETING; GENETIC LINKAGE; HYPOTHESIS; INBRED STRAIN; KIDNEY BLOOD FLOW; MICROSATELLITE MARKER; MOUSE; NEPHROSCLEROSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGENY; RECESSIVE GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOOD PRESSURE; CHROMOSOMES, MAMMALIAN; CROSSES, GENETIC; KIDNEY; KIDNEY DISEASES; LINKAGE (GENETICS); MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ANGIOTENSIN, TYPE 1; SURVIVAL ANALYSIS;

EID: 0842268280     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.0000112423.28987.00     Document Type: Article

References (24)

1. Davisson RL, Kim HS, Krege JH, Lager DJ, Smithies O, Sigmund CD. Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes. J Clin Invest. 1997; 99: 1258-1264.
2. Esther CR, Jr., Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KE. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest. 1996; 74: 953-965.
3. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995; 92: 2735-2739.
4. Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O’Brien DA, Smithies O. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature. 1995; 375: 146-148.
5. Matsusaka T, Nakazato H, Takaya J, Katori H, Kon V, Fogo A, Ichikawa A. Vascular hypertrophy in dual renin null mutant mice. J Am Soc Nephrol. 1999; 10: 350A.
6. Oliverio MI, Madsen K, Best CF, Ito M, Maeda N, Smithies O, Coffman TM. Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am J Physiol. 1998; 274: F43-F50.
7. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishimura H, Fogo A, Utsunomiya H, Inagami T, Ichikawa I. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest. 1998; 101: 755-760.
8. Yababa M, Umemura S, Kihara M, Tamura K, Nyui N, Ishigami T, Ishii M, Kiuchi Y, Yagami K, Tanimoto K, Sugiyama F, Fukamizu A, Murakami K. Altered development of vasculature in the kidney but not in other main organs in angiotensinogen-deficient mice. Hypertension. 1996; 28: 543A.
9. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, Ichiki T, Naftilan AJ, Fogo A, Inagami T, Hogan BLM, Ichikawa I. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest. 1995; 96: 2947-2954.
10. 1B receptors for angiotensin II. Proc Natl Acad Sci U S A. 1998; 95: 15496-15501.
11. Krege JH, Kim HS, Moyer JS, Jennette JC, Peng L, Hiller SK, Smithies O. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension. 1997; 29: 150-157.
12. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A. 1995; 92: 3521-3525.
13. Krege J, Hodgin J, Hagaman J, Smithies O. A computerized system for measuring blood pressure in mice. Hypertension. 1995; 25: 1111-1115.
14. Meer JM, Cudmore RH, Jr., Manly KF. Map Manager QTX17. Roswell Park Cancer Institute.
15. Garcia-Dorado A, Gallego A. On the use of the classical tests for detecting linkage. J Heredity. 1992; 83: 143-146.
16. Haley CS, Knott SA. A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity. 1992; 69: 315-374.
17. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genetics. 1995; 11: 241-247.
18. Esther CR, Marino EM, Howard TE, Machaud A, Corvol P, Capecchi MR, Bernstein KE. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest. 1997; 99: 2375-2385.
19. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989; 13: 305-314.
20. Powell JS, Clozel JP, Muller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989; 245: 186-188.
21. Miyazaki Y, Tsuchida S, Nishimura H, Pope JCT, Harris RC, McKanna JM, Inagami T, Hogan BL, Fogo A, Ichikawa I. Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest. 1998; 102: 1489-1497.
22. Kilcoyne MM, Thomson MD, Branche G, Williams M, Garnier C, Chiles B, Soland T. Characteristics of hypertension in the black population. Circulation. 1974; 50: 1006-1013.
23. Helmer OM. Renin-angiotensin system and its relation to hypertension. Progr Cardiovasc Dis. 1965; 8: 117.
24. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez, EA, Henderson WG. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Published erratum appears in N Engl J Med. 1994;330:1689. N Engl J Med. 1993; 328: 914-921.